References
-
1) Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Product: GSK3 beta Antibody (#AF5016)Year: 2016Journal: MOL MED REPImpactFactor: 3.4DOI: 10.3892/mmr.2016.5345PMID: 27221008 -
2) ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2016Journal: ONCOTARGETDOI: 10.18632/oncotarget.11699PMID: 27588482 -
3) Baicalin promotes embryo adhesion and implantation by upregulating fucosyltransferase IV (FUT4) via Wnt/beta-catenin signaling pathway.
Product: GSK3 beta Antibody (#AF5016)Year: 2015Journal: FEBS LETTImpactFactor: 3DOI: 10.1016/j.febslet.2015.04.011PMID: 25896022 -
4) Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells. Corrigendum in/mmr/12/6/8328.
Product: GSK3 beta Antibody (#AF5016)Year: 2015Journal: Mol Med RepImpactFactor: 3.4DOI: 10.3892/mmr.2014.3037PMID: 25483911 -
5) Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
Product: Chk1 Antibody (#AF5014)Year: 2017Journal: ARCH TOXICOLImpactFactor: 4.8DOI: 10.1007/s00204-016-1682-2PMID: 26914363 -
6) TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Product: JAK1 Antibody (#AF5012)Year: 2024Journal: Int ImmunopharmacolImpactFactor: 4.8DOI: 10.1016/j.intimp.2024.111494PMID: 38218012 -
7) CD163 protein inhibits lipopolysaccharide-induced macrophage transformation from M2 to M1 involved in disruption of the TWEAK-Fn14 interaction.
Product: JAK1 Antibody (#AF5012)Year: 2024Journal: HeliyonImpactFactor: 4DOI: 10.1016/j.heliyon.2023.e23223PMID: 38148798 -
8) Monotropein inhibits colitis associated cancer through VDR/JAK1/STAT1 regulation of macrophage polarization.
Product: JAK1 Antibody (#AF5012)Year: 2023Journal: Int ImmunopharmacolImpactFactor: 4.8DOI: 10.1016/j.intimp.2023.110838PMID: 37633235 -
9) CTLA4Ig/VISTAIg combination therapy selectively induces CD4+ T cell-mediated immune tolerance by targeting the SOCS1 signaling pathway in porcine islet xenotransplantation.
Product: JAK1 Antibody (#AF5012)Year: 2022Journal: IMMUNOLOGYImpactFactor: 4.9DOI: 10.1111/imm.13463PMID: 35263451 -
10) Scorpion venom polypeptide governs alveolar macrophage M1/M2 polarization to alleviate pulmonary fibrosis.
Product: JAK1 Antibody (#AF5012)Year: 2022Journal: Tissue CellImpactFactor: 2.7DOI: 10.1016/j.tice.2022.101939PMID: 36179453 -
11) Aligned electrospun poly(l-lactide) nanofibers facilitate wound healing by inhibiting macrophage M1 polarization via the JAK-STAT and NF-κB pathways.
Product: JAK1 Antibody (#AF5012)Year: 2022Journal: J NANOBIOTECHNOLImpactFactor: 10.2DOI: 10.1186/s12951-022-01549-9PMID: 35883095 -
12) Effects of Cyhalofop-butyl on the Developmental Toxicity and Immunotoxicity in Zebrafish (Danio rerio).
Product: JAK1 Antibody (#AF5012)Year: 2021Journal: CHEMOSPHEREImpactFactor: 8.1DOI: 10.1016/j.chemosphere.2020.127849PMID: 33297003 -
13) Curcumin prevents osteocyte apoptosis by inhibiting M1-type macrophage polarization in mice model of glucocorticoid-associated osteonecrosis of the femoral head.
Product: JAK1 Antibody (#AF5012)Year: 2020Journal: J ORTHOP RESImpactFactor: 2.1DOI: 10.1002/jor.24619PMID: 32009245 -
14) Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway.
Product: JAK1 Antibody (#AF5012)Year: 2018Journal: ONCOL REPImpactFactor: 3.8DOI: 10.3892/or.2018.6198PMID: 29328487 -
15) BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Product: JAK1 Antibody (#AF5012)Year: 2017Journal: MOL CARCINOGENImpactFactor: 3DOI: 10.1002/mc.22580PMID: 27770580